Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
accessing, addiction, Agler, analog, Aquestive, Blueprint, Boulevard, Cap, cessation, chosen, classroom, cocaine, Conceptual, confidence, Contempla, Cooley, COTEMPLA, cure, disincentivize, endpoint, grantor, HAP, heading, Janssen, junior, Kotkin, KVK, Lincoln, maximal, methamphetamine, milestone, molar, multicenter, narrative, nonemployee, nonrecurring, organizational, outreach, Park, partnered, partnering, pattern, Pelham, PERMP, QUILLICHEW, QULLICHEW, ratably, RBCCM, redirect, resignation, resigned, revert, SDX, Secretary, serdexmethylphenidate, SKAMP, steering, subdivision, SUD, Swanson, Takeda, Tech, turn, unrestricted, variable, winding
Removed:
abused, Acura, advisor, Aid, appeal, biopharmaceutical, blood, box, Cara, Category, Certified, chewable, Collegium, comparing, confirmed, contingency, continually, CR, crossover, Crosspark, declaratory, declare, defeat, Depomed, designing, DeWaay, differentiate, differentiation, dilaudid, direction, discovered, dissolve, Donald, Dr, DURECT, Egalet, Elite, Embeda, Energy, epidemic, equimolar, Ernst, exalgo, excessively, facing, factor, HHS, HM, hosted, House, Hysingla, IA, Inspirion, institution, intact, joined, Jr, judgement, KP, Lastly, led, liver, manipulated, metabolized, mg, moderate, MorphaBond, motor, multiplied, mutual, Mylan, nasal, Nektar, noncurrent, outnumbered, overdosing, oxycontin, peak, Pfizer, platform, POC, pose, precedent, problem, productivity, promote, Purdue, PWERM, refrain, reinforce, releasing, retroactively, Road, Roxanne, ruling, saturated, scenario, slowly, snorting, split, substantiation, Supreme, swallowing, tangible, Targiniq, Teva, theoretical, Trevena, unaudited, understand, undertook, University, unproven, vehicle, Young
Filing tables
Filing exhibits
Associated ZVRA transcripts
ZVRA similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No. 333-213926) on Form S-3 and Registration Statement (No. 333-203703, No. 333-210369, No. 333-216858 and No. 333-224062) on Form S-8 of KemPharm, Inc. of our report dated March 1, 2019, relating to the financial statements of KemPharm, Inc., appearing in this Annual Report on Form 10-K of KemPharm, Inc. for the year ended December 31, 2018.
/s/ RSM US LLP
Orlando, Florida
March 1, 2019